Ligand Inks Licensing Deal With Venture Capital Investor
socalTECH
APRIL 2, 2018
San Diego-based Ligand Pharmaceuticals said on Friday that it has entered into a deal with venture capital investor venBio Partners , which will allow venBio's portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement. READ MORE>>.
Let's personalize your content